Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it has…
GSK’s momelotinib receives orphan drug designation from US and EU watchdogs
Drugmaker GSK said on Friday that its JAK inhibitor momelotinib has been granted orphan drug designation by both…
AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
Company remains on track for a planned December 2026 evaluation of the clinical trial’s primary endpoint OCALA, Fla.,…
Astrazeneca’s Imfinzi receives green light from US FDA
Drugmaker Astrazeneca said on Friday that Imfinzi has been approved in the US as part of the first…
Nerja schoolboy gets a unanimous ‘yes’ from Britain’s Got Talent judges
Wednesday, 15 April 2026, 16:04 Twelve-year-old Juan Carlos Millón from Nerja on the eastern Costa del Sol has…
United Kingdom bans rapper Kanye West from entering due to his hateful and pro-Nazi messages
LondonThe UK’s Home Office confirmed on Tuesday that it has banned the entry into the country of The…
Britain Bars Kanye West From Entering the Country
The British government has blocked US rapper Kanye West from entering the United Kingdom on the grounds that…